UBS’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

UBS’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-2	Closed	-$4.73K	–	10953
2013 Q4	$4K	Buy	+2	New	+$4.73K	﹤0.01%	9752

Other funds holding AMPE

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NFG

Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS's AMPE Position: Q1 2014 in Review

UBS sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2014, closing a stake of 2 shares — an estimated $4.73K sold.

UBS first reported a position in AMPE in Q4 2013 and held it in 1 quarter. The position peaked at $4K in Q4 2013. 78 funds tracked by Wall St. Rank hold AMPE as of Q1 2014.

UBS reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2014 after selling out during the quarter.
UBS sold 2 Ampio Pharmaceuticals Inc. shares in Q1 2014, an estimated $4.73K.
UBS first reported a position in Ampio Pharmaceuticals Inc. in Q4 2013 and held it in 1 quarter.
UBS's Ampio Pharmaceuticals Inc. position peaked at $4K in Q4 2013.
78 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2014.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.